Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi ...

The NHS has announced that it will fast-track patients with advanced head and neck cancers in England into a clinical trial of an investigational cancer vaccine. Over 100 patients will be matched to ...

Global non-profit organisation DEBRA Research and Queen Mary University of London have entered into a partnership aimed at advancing drug development for epidermolysis bullosa (EB).

This statistic highlights the increasing importance of technology in healthcare and underscores the need to balance clinical responsibilities with the growing technological demands on providers. For ...

Let’s be honest, ‘client service’ is one of the most lifeless phrases in our industry. It confines people to their accounts and frames relationships as ...

Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) as ...

With the changes at NHS England and the publishing of the 10-Year Plan, there is a lot of talk of change in the NHS in ...

This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial ...

ASCO® 2025 wasn’t only about oncology breakthroughs - it was also a showcase for how technology is redefining congress ...

Botanical drugs are stepping into the space between traditional remedies and modern pharmaceuticals. These are not ...